Basak S - Search Results

1

Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression.

Brady CA, Jiang D, Mello SS, Johnson TM, Jarvis LA, Kozak MM, Kenzelmann Broz D, Basak S, Park EJ, McLaughlin ME, Karnezis AN, Attardi LD. Brady CA, et al. Among authors: basak s. Cell. 2011 May 13;145(4):571-83. doi: 10.1016/j.cell.2011.03.035. Cell. 2011. PMID: 21565614 Free PMC article.

2

The metastasis-associated gene Prl-3 is a p53 target involved in cell-cycle regulation.

Basak S, Jacobs SB, Krieg AJ, Pathak N, Zeng Q, Kaldis P, Giaccia AJ, Attardi LD. Basak S, et al. Mol Cell. 2008 May 9;30(3):303-14. doi: 10.1016/j.molcel.2008.04.002. Mol Cell. 2008. PMID: 18471976 Free PMC article.

3

Siva is an apoptosis-selective p53 target gene important for neuronal cell death.

Jacobs SB, Basak S, Murray JI, Pathak N, Attardi LD. Jacobs SB, et al. Among authors: basak s. Cell Death Differ. 2007 Jul;14(7):1374-85. doi: 10.1038/sj.cdd.4402128. Epub 2007 Apr 20. Cell Death Differ. 2007. PMID: 17464332

4

miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells.

Noonan EJ, Place RF, Basak S, Pookot D, Li LC. Noonan EJ, et al. Among authors: basak s. Oncotarget. 2010 Sep;1(5):349-58. doi: 10.18632/oncotarget.167. Oncotarget. 2010. PMID: 20948989 Free PMC article.

5

Genistein down-regulates androgen receptor by modulating HDAC6-Hsp90 chaperone function.

Basak S, Pookot D, Noonan EJ, Dahiya R. Basak S, et al. Mol Cancer Ther. 2008 Oct;7(10):3195-202. doi: 10.1158/1535-7163.MCT-08-0617. Mol Cancer Ther. 2008. PMID: 18852123

6

Toxic and chemopreventive ligands preferentially activate distinct aryl hydrocarbon receptor pathways: implications for cancer prevention.

Okino ST, Pookot D, Basak S, Dahiya R. Okino ST, et al. Among authors: basak s. Cancer Prev Res (Phila). 2009 Mar;2(3):251-6. doi: 10.1158/1940-6207.CAPR-08-0146. Epub 2009 Feb 17. Cancer Prev Res (Phila). 2009. PMID: 19223575

7

miR-449a targets HDAC-1 and induces growth arrest in prostate cancer.

Noonan EJ, Place RF, Pookot D, Basak S, Whitson JM, Hirata H, Giardina C, Dahiya R. Noonan EJ, et al. Among authors: basak s. Oncogene. 2009 Apr 9;28(14):1714-24. doi: 10.1038/onc.2009.19. Epub 2009 Mar 2. Oncogene. 2009. PMID: 19252524

8

A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumours.

Aung KL, El-Khoueiry AB, Gelmon K, Tran B, Bajaj G, He B, Chen T, Zhu L, Poojary S, Basak S, Qi Z, Spreafico A, Fischer BS, Desai J. Aung KL, et al. Among authors: basak s. Invest New Drugs. 2018 Dec;36(6):1026-1036. doi: 10.1007/s10637-018-0597-6. Epub 2018 Apr 10. Invest New Drugs. 2018. PMID: 29637471 Free PMC article. Clinical Trial.

9

Epidermal growth factor receptor T790M testing in progressed lung cancer: A review of sensitive methods for analysis of tissue and liquid biopsy samples.

Chougule A, Basak S. Chougule A, et al. Among authors: basak s. Indian J Cancer. 2017 Dec;54(Supplement):S45-S54. doi: 10.4103/ijc.IJC_540_17. Indian J Cancer. 2017. PMID: 29292708 Free article. Review.

10

Biodiversity of the Bacterial and Fungal Microbiome and Associated Inflammatory Cytokine Profile in Chronic Rhinosinusitis.

Yang HH, Simpson CA, Srivastava M, Bera A, Cappelletti M, Suh JD, Wang M, Beswick DM, Maxim T, Basak SK, Srivatsan ES, Fischer JL, Jacobs JP, Lee JT. Yang HH, et al. Among authors: basak sk. Int Forum Allergy Rhinol. 2025 Jan 8. doi: 10.1002/alr.23519. Online ahead of print. Int Forum Allergy Rhinol. 2025. PMID: 39776217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

862 results

Search Page

Filters